Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2012; 18(10): 1021-1027
Published online Mar 14, 2012. doi: 10.3748/wjg.v18.i10.1021
Published online Mar 14, 2012. doi: 10.3748/wjg.v18.i10.1021
Table 2 Results of treatment with botulinum toxin A
| Frequency | Percent (%) | |
| Botox dose | ||
| 20 IU | 3 | 5.1 |
| 30 IU | 11 | 18.6 |
| 50 IU | 45 | 76.3 |
| Site of injection | ||
| Unspecified - internal sphincter | 1 | 1.7 |
| Posterior side internal sphincter | 2 | 3.4 |
| Anterior side internal sphincter | 56 | 94.9 |
| Resting anal tone | ||
| Normal | 1 | 1.7 |
| Increased | 58 | 98.3 |
| Maximal voluntary anal squeeze | ||
| Normal | 4 | 6.8 |
| Increased | 53 | 89.8 |
| Decreased | 2 | 3.4 |
| Pubo-rectal muscle relaxation | ||
| Present | 58 | 98.3 |
| Absent | 1 | 1.7 |
- Citation: Vanella S, Brisinda G, Marniga G, Crocco A, Bianco G, Maria G. Botulinum toxin for chronic anal fissure after biliopancreatic diversion for morbid obesity. World J Gastroenterol 2012; 18(10): 1021-1027
- URL: https://www.wjgnet.com/1007-9327/full/v18/i10/1021.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i10.1021